Pharmacokinetics and Safety of Imeglimin in Japanese Patients with Impaired Renal Function.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of clinical pharmacology"
DOI: 10.1002/jcph.2218
Abstract: Imeglimin is a diabetic drug excreted mainly in the urine; therefore, the impact of renal impairment on its pharmacokinetics (PK) is of interest. We assessed the PK and safety of imeglimin in Japanese patients with… read more here.
Keywords: function; safety imeglimin; renal impairment; renal function ... See more keywords